Rossmore Private Capital’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.04M | Hold |
5,635
| – | – | 0.17% | 96 |
|
|
2026
Q1 | $1.98M | Sell |
5,635
-32
| -0.6% | -$11.4K | 0.17% | 92 |
|
|
2025
Q4 | $1.85M | Buy |
5,667
+1,195
| +27% | +$379K | 0.17% | 100 |
|
|
2025
Q3 | $1.26M | Buy |
4,472
+421
| +10% | +$122K | 0.14% | 120 |
|
|
2025
Q2 | $1.13M | Buy |
4,051
+102
| +3% | +$28.9K | 0.13% | 123 |
|
|
2025
Q1 | $1.23M | Sell |
3,949
-30
| -0.8% | -$8.86K | 0.15% | 118 |
|
|
2024
Q4 | $1.04M | Sell |
3,979
-29
| -0.7% | -$8.6K | 0.13% | 122 |
|
|
2024
Q3 | $1.29M | Hold |
4,008
| – | – | 0.16% | 104 |
|
|
2024
Q2 | $1.25M | Hold |
4,008
| – | – | 0.16% | 101 |
|
|
2024
Q1 | $1.14M | Hold |
4,008
| – | – | 0.15% | 114 |
|
|
2023
Q4 | $1.15M | Sell |
4,008
-115
| -3% | -$31.3K | 0.16% | 105 |
|
|
2023
Q3 | $1.11M | Buy |
4,123
+50
| +1% | +$12.5K | 0.17% | 103 |
|
|
2023
Q2 | $904K | Buy |
4,073
+45
| +1% | +$10.4K | 0.13% | 123 |
|
|
2023
Q1 | $974K | Sell |
4,028
-5
| -0.1% | -$1.23K | 0.15% | 112 |
|
|
2022
Q4 | $1.06M | Buy |
4,033
+166
| +4% | +$44.5K | 0.17% | 101 |
|
|
2022
Q3 | $872K | Buy |
3,867
+243
| +7% | +$58.9K | 0.16% | 109 |
|
|
2022
Q2 | $882K | Buy |
3,624
+619
| +21% | +$152K | 0.15% | 112 |
|
|
2022
Q1 | $727K | Sell |
3,005
-51
| -2% | -$11.7K | 0.11% | 131 |
|
|
2021
Q4 | $688K | Sell |
3,056
-140
| -4% | -$29.5K | 0.11% | 139 |
|
|
2021
Q3 | $680K | Buy |
3,196
+100
| +3% | +$23K | 0.12% | 134 |
|
|
2021
Q2 | $755K | Sell |
3,096
-99
| -3% | -$24.4K | 0.13% | 125 |
|
|
2021
Q1 | $795K | Sell |
3,195
-978
| -23% | -$233K | 0.15% | 116 |
|
|
2020
Q4 | $959K | Buy |
4,173
+18
| +0.4% | +$4.15K | 0.19% | 102 |
|
|
2020
Q3 | $1.06M | Buy |
4,155
+300
| +8% | +$74.3K | 0.25% | 95 |
|
|
2020
Q2 | $909K | Buy |
3,855
+682
| +21% | +$156K | 0.25% | 88 |
|
|
2020
Q1 | $643K | Sell |
3,173
-52
| -2% | -$11.4K | 0.22% | 96 |
|
|
2019
Q4 | $777K | Hold |
3,225
| – | – | 0.24% | 72 |
|
|
2019
Q3 | $624K | Buy |
3,225
+30
| +0.9% | +$5.76K | 0.21% | 79 |
|
|
2019
Q2 | $589K | Hold |
3,195
| – | – | 0.21% | 79 |
|
|
2019
Q1 | $607K | Buy |
3,195
+150
| +5% | +$28.6K | 0.22% | 77 |
|
|
2018
Q4 | $593K | Buy |
3,045
+200
| +7% | +$39K | 0.25% | 71 |
|
|
2018
Q3 | $590K | Buy |
2,845
+570
| +25% | +$112K | 0.24% | 69 |
|
|
2018
Q2 | $420K | Hold |
2,275
| – | – | 0.27% | 67 |
|
|
2018
Q1 | $388K | Buy |
2,275
+1,100
| +94% | +$202K | 0.39% | 55 |
|
|
2017
Q4 | $204K | Buy |
+1,175
| New | +$208K | 0.21% | 89 |
|
Other funds holding AMGN
Rossmore Private Capital's AMGN Position: Q2 2026 in Review
Rossmore Private Capital held its Amgen (AMGN) position steady in Q2 2026 at 5,635 shares worth $2.04M. The position accounts for 0.17% of the portfolio, ranked #96.
Rossmore Private Capital first reported a position in AMGN in Q4 2017 and has held it in 35 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Rossmore Private Capital held 5,635 shares of Amgen worth $2.04M as of Q2 2026.
- Rossmore Private Capital left its Amgen share count unchanged in Q2 2026.
- Amgen made up 0.17% of Rossmore Private Capital's portfolio in Q2 2026, its #96 holding.
- Rossmore Private Capital first reported a position in Amgen in Q4 2017 and has held it in 35 quarters since.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Rossmore Private Capital's 13F filing for Q2 2026, filed 31 Jul 2026.